Viking Therapeutics to Report Financial Results for First Quarter 2020 on April 30, 2020
Go back to Viking Therapeutics to Report Financial Results for First Quarter 2020 on April 30, 2020| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 72.02 +3.16 (4.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.86 | 52 Week High | $5.17 | |||
| Open | $69.00 | 52 Week Low | $0.94 | |||
| Day High | $72.49 | P/E | N/A | |||
| Day Low | $68.22 | EPS | $0.00 | |||
| Volume | 2,003,033 | |||||
